Key Insights

Highlights

Success Rate

86% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

7.1%

3 terminated out of 42 trials

Success Rate

86.4%

-0.1% vs benchmark

Late-Stage Pipeline

7%

3 trials in Phase 3/4

Results Transparency

11%

2 of 19 completed with results

Key Signals

2 with results86% success

Data Visualizations

Phase Distribution

28Total
Not Applicable (16)
Early P 1 (1)
P 1 (6)
P 2 (2)
P 3 (2)
P 4 (1)

Trial Status

Completed19
Unknown13
Recruiting3
Terminated3
Withdrawn2
Active Not Recruiting1

Trial Success Rate

86.4%

Benchmark: 86.5%

Based on 19 completed trials

Clinical Trials (42)

Showing 20 of 20 trials
NCT04519671Phase 1Terminated

Mesenchymal Stem Cells for the Treatment of Perianal Fistulizing Crohn's Disease

NCT07519850Recruiting

The Impact of Perianal Disease on Patient's Sex Life

NCT07477496Recruiting

Recurrence and Anal Fistula Patient Reported Outcomes Trial

NCT04549311Phase 3Completed

Perianal Abscess Recurrence and Fistula Formation: Antibiotics Following Incision and Drainage Trial

NCT03707769Not ApplicableCompletedPrimary

TIPS Microspheres for Perianal Fistula

NCT07236047Not ApplicableNot Yet RecruitingPrimary

Comparing Three Surgical Techniques for the Treatment of Transsphincteric Perianal Fistula: (1) Traditional Fistulotomy (Lay Open), (2) Ligation of the Intersphincteric Tract (LIFT) With Adjunctive Endo Fistula Laser Ablation, and (3) Open LIFT Procedure Followed by LASER

NCT06527833Not ApplicableCompletedPrimary

Procedure-Specific Approach To Minimize Fistulaization of The Perianal Abscess Cavity After Surgical Drainage

NCT05626023Phase 1CompletedPrimary

A Study of Human TH-SC01 Cell Injection for Treating Perianal Fistulas in Patients With Crohn's Disease

NCT05836883Phase 1TerminatedPrimary

Study of ExoFlo for the Treatment of Perianal Fistulas

NCT06616662CompletedPrimary

Transsphincteric Fistula Management Using LIFT and MAF

NCT04847739Phase 2Active Not RecruitingPrimary

Seeded Cells on Matrix Plug Treating Crohn's Perianal Fistulas (STOMP-II)

NCT06446635Not ApplicableRecruitingPrimary

Semiflex Assisted Vacuum Therapy for Perianal Abscesses/Sinuses and Fistula: a Pilot Study

NCT06441526Phase 3CompletedPrimary

Surgical Closure vs Anti-TNF in the Treatment of Perianal Fistulas in Crohn's Disease (PISA-II): a Comprehensive Cohort Design

NCT04722965Not ApplicableWithdrawnPrimary

Treatment of Lower Transsphincteric Perianal Fistula: Fistulotomy With Marsupialization vs Open Wound

NCT06314945CompletedPrimary

Diagnostic Value of Recto-perineal Ultrasound in Perianal Fistula

NCT05385887Not ApplicableUnknownPrimary

Antibiotic Treatment foLlowing Surgical drAinage of Perianal abScess; the ATLAS Trial

NCT05990569Not ApplicableUnknown

Pudendal Nerve Block With Bupivacaine Alone and Bupivacaine With Methylene Blue for Postoperative Analgesia

NCT05721794Unknown

Comparative Accuracy of Transperineal Ultrasound (TPUS) Versus Magnetic Resonance Imaging (MRI) for the Assessment of Perianal Fistulae in Patients With Crohn's Disease (CD): a Prospective Observational Longitudinal Cohort Study

NCT05709717UnknownPrimary

Regenerative Therapy With Autologous Stromal Vascular Fraction Derived Mesenchymal Stem Cells and Platelet-rich Plasma to Treat Complex Perianal Diseases

NCT03861689Not ApplicableUnknown

Tight Control Management in Perianal Crohn's Disease

Scroll to load more

Research Network

Activity Timeline